What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.

IF 3.1 Q2 PHARMACOLOGY & PHARMACY
Hanieh Abbasi, Maryam Kouchak, Zohreh Mirveis, Fatemeh Hajipour, Mohsen Khodarahmi, Nadereh Rahbar, Somayeh Handali
{"title":"What We Need to Know about Liposomes as Drug Nanocarriers: An Updated Review.","authors":"Hanieh Abbasi,&nbsp;Maryam Kouchak,&nbsp;Zohreh Mirveis,&nbsp;Fatemeh Hajipour,&nbsp;Mohsen Khodarahmi,&nbsp;Nadereh Rahbar,&nbsp;Somayeh Handali","doi":"10.34172/apb.2023.009","DOIUrl":null,"url":null,"abstract":"<p><p>Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the \"first-generation\" liposomes.</p>","PeriodicalId":7256,"journal":{"name":"Advanced pharmaceutical bulletin","volume":"13 1","pages":"7-23"},"PeriodicalIF":3.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871273/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced pharmaceutical bulletin","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/apb.2023.009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Liposomes have been attracted considerable attention as phospholipid spherical vesicles, over the past 40 years. These lipid vesicles are valued in biomedical application due to their ability to carry both hydrophobic and hydrophilic agents, high biocompatibility and biodegradability. Various methods have been used for the synthesis of liposomes, so far and numerous modifications have been performed to introduce liposomes with different characteristics like surface charge, size, number of their layers, and length of circulation in biological fluids. This article provides an overview of the significant advances in synthesis of liposomes via active or passive drug loading methods, as well as describes some strategies developed to fabricate their targeted formulations to overcome limitations of the "first-generation" liposomes.

Abstract Image

Abstract Image

Abstract Image

我们需要知道的关于脂质体作为药物纳米载体:最新综述。
脂质体作为一种球形磷脂囊泡,在过去的40年中受到了广泛的关注。这些脂质囊泡在生物医学应用中有价值,因为它们具有携带疏水和亲水剂的能力,高生物相容性和生物降解性。脂质体的合成方法多种多样,到目前为止,已经进行了大量的修饰,以引入具有不同特征的脂质体,如表面电荷、大小、层数和生物流体中的循环长度。本文概述了通过主动或被动药物装载方法合成脂质体的重大进展,并描述了为克服“第一代”脂质体的局限性而开发的制造其靶向制剂的一些策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced pharmaceutical bulletin
Advanced pharmaceutical bulletin PHARMACOLOGY & PHARMACY-
CiteScore
6.80
自引率
2.80%
发文量
51
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信